4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline

C85H81N27O2 — CID 158186414

IUPAC4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline
SMILESCOc1cc2nc(-c3cn[nH]c3C)c3c(c2c2cn[nH]c12)CCCC3.Cc1[nH]ncc1-c1cc(N2CCN(C)CC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(N2CCOCC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1ccc2c3c(ccc2n1)C=NC3.Cc1[nH]ncc1-c1ccc2ccc3cn[nH]c3c2n1
InChIInChI=1S/C19H21N7.C19H19N5O.C18H18N6O.C15H12N4.C14H11N5/c1-12-13(10-20-23-12)17-9-18(26-7-5-25(2)6-8-26)19-14-11-21-24-15(14)3-4-16(19)22-17;1-10-13(8-20-23-10)18-12-6-4-3-5-11(12)17-14-9-21-24-19(14)16(25-2)7-15(17)22-18;1-11-12(9-19-22-11)16-8-17(24-4-6-25-7-5-24)18-13-10-20-23-14(13)2-3-15(18)21-16;1-9-12(8-17-19-9)15-5-3-11-13-7-16-6-10(13)2-4-14(11)18-15;1-8-11(7-16-18-8)12-5-4-9-2-3-10-6-15-19-14(10)13(9)17-12/h3-4,9-11H,5-8H2,1-2H3,(H,20,23)(H,21,24);7-9H,3-6H2,1-2H3,(H,20,23)(H,21,24);2-3,8-10H,4-7H2,1H3,(H,19,22)(H,20,23);2-6,8H,7H2,1H3,(H,17,19);2-7H,1H3,(H,15,19)(H,16,18)
InChIKeyFZERCNJEHTWLDM-UHFFFAOYSA-N
MW1512.77 g/mol
LogP14.58
Rot. Bonds8

About 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline

4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline (PubChem CID 158186414) has the molecular formula C85H81N27O2 and a molecular weight of 1512.77 g/mol. Its IUPAC name is 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline.

Molecular Properties

Compound Name4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline
PubChem CID158186414
Molecular FormulaC85H81N27O2
Molecular Weight1512.77 g/mol
Exact Mass1511.71
IUPAC Name4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline
SMILESCOc1cc2nc(-c3cn[nH]c3C)c3c(c2c2cn[nH]c12)CCCC3.Cc1[nH]ncc1-c1cc(N2CCN(C)CC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(N2CCOCC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1ccc2c3c(ccc2n1)C=NC3.Cc1[nH]ncc1-c1ccc2ccc3cn[nH]c3c2n1
InChIInChI=1S/C19H21N7.C19H19N5O.C18H18N6O.C15H12N4.C14H11N5/c1-12-13(10-20-23-12)17-9-18(26-7-5-25(2)6-8-26)19-14-11-21-24-15(14)3-4-16(19)22-17;1-10-13(8-20-23-10)18-12-6-4-3-5-11(12)17-14-9-21-24-19(14)16(25-2)7-15(17)22-18;1-11-12(9-19-22-11)16-8-17(24-4-6-25-7-5-24)18-13-10-20-23-14(13)2-3-15(18)21-16;1-9-12(8-17-19-9)15-5-3-11-13-7-16-6-10(13)2-4-14(11)18-15;1-8-11(7-16-18-8)12-5-4-9-2-3-10-6-15-19-14(10)13(9)17-12/h3-4,9-11H,5-8H2,1-2H3,(H,20,23)(H,21,24);7-9H,3-6H2,1-2H3,(H,20,23)(H,21,24);2-3,8-10H,4-7H2,1H3,(H,19,22)(H,20,23);2-6,8H,7H2,1H3,(H,17,19);2-7H,1H3,(H,15,19)(H,16,18)
InChIKeyFZERCNJEHTWLDM-UHFFFAOYSA-N
XLogP14.58
TPSA363.11 Ų
H-Bond Donors9
H-Bond Acceptors20
Rotatable Bonds8
Heavy Atoms114
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001512.77
LogP ≤ 514.58
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1020

Analyze 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline?
The IUPAC name of 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline (CID 158186414) is 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline.
What is the SMILES notation for 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline?
The canonical SMILES for 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline is COc1cc2nc(-c3cn[nH]c3C)c3c(c2c2cn[nH]c12)CCCC3.Cc1[nH]ncc1-c1cc(N2CCN(C)CC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(N2CCOCC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1ccc2c3c(ccc2n1)C=NC3.Cc1[nH]ncc1-c1ccc2ccc3cn[nH]c3c2n1.
What is the InChIKey of 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline?
The InChIKey is FZERCNJEHTWLDM-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H21N7.C19H19N5O.C18H18N6O.C15H12N4.C14H11N5/c1-12-13(10-20-23-12)17-9-18(26-7-5-25(2)6-8-26)19-14-11-21-24-15(14)3-4-16(19)22-17;1-10-13(8-20-23-10)18-12-6-4-3-5-11(12)17-14-9-21-24-19(14)16(25-2)7-15(17)22-18;1-11-12(9-19-22-11)16-8-17(24-4-6-25-7-5-24)18-13-10-20-23-14(13)2-3-15(18)21-16;1-9-12(8-17-19-9)15-5-3-11-13-7-16-6-10(13)2-4-14(11)18-15;1-8-11(7-16-18-8)12-5-4-9-2-3-10-6-15-19-14(10)13(9)17-12/h3-4,9-11H,5-8H2,1-2H3,(H,20,23)(H,21,24);7-9H,3-6H2,1-2H3,(H,20,23)(H,21,24);2-3,8-10H,4-7H2,1H3,(H,19,22)(H,20,23);2-6,8H,7H2,1H3,(H,17,19);2-7H,1H3,(H,15,19)(H,16,18).
What are the key properties of 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline?
4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline has a molecular weight of 1512.77 g/mol, XLogP of 14.58, 8 rotatable bonds, 9 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline is sourced from PubChem (CID 158186414), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).